Medical News

RSS

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

"No one denies" that the oral polio vaccine "has considerable merits. It's cheap to make. It's easy to administer; you don't need a trained nurse with a clean syringe [like the inactive vaccine needs], just a volunteer with a dropper. And it gives excellent immunity. ... But there are problems with the method," Wendy Orent, author of the book Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease, writes in a Los Angeles Times opinion piece.

10 Feb 2011

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

10 Feb 2011

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).

10 Feb 2011

Cephalon to acquire Alba Therapeutics

Cephalon, Inc. and Alba Therapeutics Corporation, a privately held biopharmaceutical company, today announced that the companies have signed an agreement providing Cephalon with an option to purchase all of Alba's assets relating to larazotide acetate, a tight junction modulator, progressing toward a Phase IIb clinical trial for the treatment of celiac disease.

10 Feb 2011

New study: Fetal surgery for spina bifida greatly improves child's mobility

Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children's Hospital of Philadelphia co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.

9 Feb 2011

People with memory problems may face high risk of stroke

People who have memory problems or other declines in their mental abilities may be at higher risk for stroke, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

9 Feb 2011

Johns Hopkins funds 12 research groups to launch new BSi program on cognitive disorders

The Johns Hopkins Brain Sciences Institute has funded a total of $5 million to 12 different research groups at Hopkins to launch the new Synapses, Circuits and Cognitive Disorders Program. The new BSi program aims to understand the fundamentals of brain function by focusing on the synapse — the point of contact between two nerve cells — to better understand cognitive disorders.

9 Feb 2011

Everolimus phase III study shows improved progression-free survival in patients with pNET

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin, has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors, according to researchers from The University of Texas MD Anderson Cancer Center.

9 Feb 2011

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

Microsponges derived from seaweed may help diagnose heart disease, cancers, HIV and other diseases quickly and at far lower cost than current clinical methods. The microsponges are an essential component of Rice University's Programmable Bio-Nano-Chip (PBNC) and the focus of a new paper in the journal Small.

9 Feb 2011

New study: Testosterone administration leads to significant reduction in mind reading

A new study from Utrecht and Cambridge Universities has for the first time found that an administration of testosterone under the tongue in volunteers negatively affects a person's ability to 'mind read', an indication of empathy. The findings are published this week in the journal Proceedings of the National Academy of Sciences.

9 Feb 2011

Genmed announces Suprafen drug registration with Dutch MEB

Genmed Holding Corp. has announced its next generic drug registration. The Company will file it's dossier for the drug Suprafen, otherwise known as Ibuprofen, with the Dutch Medicines Evaluation Board in the coming months. Suprafen is a non-steroidal anti-inflammatory as well as an analgesic.

9 Feb 2011

Two community health centers receive GE grant to provide increased access to healthcare in the US

The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 to two Erie-based community health centers in an effort to help increase access to quality healthcare across the United States.

9 Feb 2011

FDA clears EOS orthopedic imaging system for use in lower limbs applications

EOS imaging announced today that it has received FDA clearance of its sterEOS 3D orthopedic imaging workstation for use in lower limbs applications for patients 15 years and older.

9 Feb 2011

Humana Military introduces new website for mobile phones and tablets

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc., announces the launch of the mobile Humana Military website for mobile phones and tablets.

9 Feb 2011

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of separate Phase 2 clinical studies of its product candidate TC-6987 in disorders characterized by inflammation, one in asthma and one in Type 2 diabetes.

9 Feb 2011

Mobily introduces first mobile medical imaging service

Saudi Arabian telecommunications company Mobily and Great Connection Inc., creator of the innovative Mobile Baby service, announced the launch of the first mobile medical imaging service that enables ultrasound stills, 3D images and video clips to be sent directly from an ultrasound machine to a mobile device.

9 Feb 2011

Evotec signs definitive agreement to acquire all shares in Kinaxo

Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.

9 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

Study: E-cigarettes are safer alternative to tobacco smoking

A study just released by the Journal of Public Health Policy is taking a closer look at traditional tobacco cigarettes vs. e-cigarettes, and the results are surprising even the biggest skeptics. Based on available evidence, the study "Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes?" concluded that e-cigarettes are safer than tobacco cigarettes, and have the potential to become a smoking cessation device.

9 Feb 2011

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

What happens to young adults with autism spectrum disorders (ASDs) once they graduate high school and are no longer entitled to services?

9 Feb 2011

Medical News

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Cephalon to acquire Alba Therapeutics

New study: Fetal surgery for spina bifida greatly improves child's mobility

People with memory problems may face high risk of stroke

Johns Hopkins funds 12 research groups to launch new BSi program on cognitive disorders

Everolimus phase III study shows improved progression-free survival in patients with pNET

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

New study: Testosterone administration leads to significant reduction in mind reading

Genmed announces Suprafen drug registration with Dutch MEB

Two community health centers receive GE grant to provide increased access to healthcare in the US

FDA clears EOS orthopedic imaging system for use in lower limbs applications

Humana Military introduces new website for mobile phones and tablets

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

Mobily introduces first mobile medical imaging service

Evotec signs definitive agreement to acquire all shares in Kinaxo

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Study: E-cigarettes are safer alternative to tobacco smoking

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News